UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

17-05: Health Economic Analysis of Left Atrial Appendage Closure from Randomised Controlled Trial and Real-World Experience Relative to Oral Anticoagulation by CHA2DS2-VASc sub-group

Europace (London, England), 2016-06, Vol.18 (suppl_1), p.i162-i162

2016

Volltextzugriff (PDF)

229-06: Left Atrial Appendage Electrical Isolation for Long-Standing Persistent Atrial Fibrillation: Computational Three-Dimensional Left Atrial Appendage Wall Thickness Maps and Histological Analysis to Guide Ablation

Europace (London, England), 2016-06, Vol.18 (suppl_1), p.i160-i160

2016

Volltextzugriff (PDF)

Revolutionary Outcomes in Iran and Nicaragua: Coalition Fragmentation, War, and the Limits of Social Transformation

Theory and society, 1993-04, Vol.22 (2), p.209-247

1993

Volltextzugriff (PDF)

The Strengths and Weaknesses of Iran's Populist Alliance: A Class Analysis of the Constitutional Revolution of 1905-1911

Theory and society, 1991-12, Vol.20 (6), p.795-823

Foran, John

1991

Volltextzugriff (PDF)

Surgical procedures in the management of Takayasu's arteritis

Journal of vascular surgery, 1990-10, Vol.12 (4), p.429-439

1990

Volltextzugriff (PDF)

Yugoslavia: Poisoning or epidemic hysteria in Kosovo?

The Lancet (British edition), 1991, Vol.338 (8776), p.1196-1196

1991

Volltextzugriff (PDF)

Brief Report: A Novel Digital Therapeutic that Combines Applied Behavior Analysis with Gaze-Contingent Eye Tracking to Improve Emotion Recognition in Children with Autism Spectrum Disorder

Journal of autism and developmental disorders, 2022-05, Vol.52 (5), p.2357-2366

2022

Volltextzugriff (PDF)

A Review of Heart Rate and Blood Pressure Responses to Active Standing in Healthy Adults

Current aging science, 2022-11, Vol.15 (3), p.198-208

2022

Volltextzugriff (PDF)

Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7043-7043

2018

Volltextzugriff (PDF)

Obesity in Adult AML is Not Associated with Inferior Response or Survival Even When Dose Capping Anthracyclines: An ECOG-ACRIN analysis

Cancer, 2023-04, Vol.129 (16), p.2479-2490

2023

Volltextzugriff (PDF)

AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S309-S310

2023

Volltextzugriff (PDF)

POSTER: AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S167-S167

2023

Volltextzugriff (PDF)

Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS6091-TPS6091

2017

Volltextzugriff (PDF)

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB‐B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

HemaSphere, 2023-08, Vol.7 (S3), p.e2941723-n/a

2023

Volltextzugriff (PDF)

Patient Perception of Physician Reimbursement in Elective Shoulder Surgery

Journal of shoulder and elbow surgery, 2013-04, Vol.22 (4), p.e41-e41

2013

Volltextzugriff (PDF)

Activity of the oral MEK inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

Cancer, 2016-03, Vol.122 (12), p.1871-1879

2016

Volltextzugriff (PDF)

Accessing specialist early intervention services for pre-school children: A lack of co-ordination in the delivery of early intervention to children with an intellectual disability in Ireland led Sinéad Foran and John Sweeney to examine the lived experiences of families accessing services

Learning disability practice, 2010-03, Vol.13 (2), p.30-35

2010

Volltextzugriff (PDF)

Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients

Clinical lymphoma, myeloma and leukemia, 2016-09, Vol.16, p.S28-S28

2016

Volltextzugriff (PDF)

The Conviction of Dr. Crippen: New Forensic Findings in a Century-Old Murder: THE CONVICTION OF DR. CRIPPEN

Journal of forensic sciences, 2011-01, Vol.56 (1), p.233-240

2011

Volltextzugriff (PDF)

ORAL ABSTRACTS (2)EP & Ablation19CARDIAC ABLATION PATIENT REPORTED OUTCOMES MEASURES (PROMS): ANALYSIS OF POST-ABLATION AND 1 YEAR FOLLOW-UP DATA20INTENTIONAL CORONARY VEIN EXIT AND CARBON DIOXIDE INSUFFLATION TO ALLOW SAFE SUBXIPHOID EPICARDIAL ACCESS FOR VENTRICULAR MAPPING AND ABLATION - FIRST EXPERIENCE21PACED FRACTIONATION DETECTION AS A TOOL FOR MAPPING SCARS IN VT22DOES USE OF CONTACT-FORCE SENSING CATHETERS IMPROVE THE OUTCOME OF ABLATION OF VENTRICULAR TACHYCARDIA?23RETROGRADE AORTIC AC

Europace (London, England), 2016-10, Vol.18 (suppl 2), p.ii8-ii12

2016

Volltextzugriff (PDF)

Phase Ib trial of AVL-292, a covalent inhibitor of Bruton's tyrosine kinase (Btk), in chronic lymphocytic leukemia (CLL) and B-non-Hodgkin lymphoma (B-NHL)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8032-8032

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)
Berichte
(1)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

17-05: Health Economic Analysis of Left Atrial Appendage Closure from Randomised Controlled Trial and Real-World Experience Relative to Oral Anticoagulation by CHA2DS2-VASc sub-group

229-06: Left Atrial Appendage Electrical Isolation for Long-Standing Persistent Atrial Fibrillation: Computational Three-Dimensional Left Atrial Appendage Wall Thickness Maps and Histological Analysis to Guide Ablation

Revolutionary Outcomes in Iran and Nicaragua: Coalition Fragmentation, War, and the Limits of Social Transformation

The Strengths and Weaknesses of Iran's Populist Alliance: A Class Analysis of the Constitutional Revolution of 1905-1911

Surgical procedures in the management of Takayasu's arteritis

Yugoslavia: Poisoning or epidemic hysteria in Kosovo?

Brief Report: A Novel Digital Therapeutic that Combines Applied Behavior Analysis with Gaze-Contingent Eye Tracking to Improve Emotion Recognition in Children with Autism Spectrum Disorder

A Review of Heart Rate and Blood Pressure Responses to Active Standing in Healthy Adults

Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML

Obesity in Adult AML is Not Associated with Inferior Response or Survival Even When Dose Capping Anthracyclines: An ECOG-ACRIN analysis

AML-545 Long-Term Follow-up Demonstrates Ongoing Efficacy Benefit of 131I-Apamistamab-led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML in the Phase 3 SIERRA Trial

Long-Term Follow-Up Demonstrates Ongoing Efficacy Benefit of 131I-Apamistamab-led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML in the Phase 3 SIERRA Trial

AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies

POSTER: AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies

Phase III randomised controlled trial (RCT) comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer (CompARE)

AML-123: Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Engraftment in Older Patients with Active, Relapsed, or Refractory (rel/ref) AML: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 SIERRA Trial

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB‐B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

Patient Perception of Physician Reimbursement in Elective Shoulder Surgery

Activity of the oral MEK inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

Accessing specialist early intervention services for pre-school children: A lack of co-ordination in the delivery of early intervention to children with an intellectual disability in Ireland led Sinéad Foran and John Sweeney to examine the lived experiences of families accessing services

Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients

The Conviction of Dr. Crippen: New Forensic Findings in a Century-Old Murder: THE CONVICTION OF DR. CRIPPEN

Phase Ib trial of AVL-292, a covalent inhibitor of Bruton's tyrosine kinase (Btk), in chronic lymphocytic leukemia (CLL) and B-non-Hodgkin lymphoma (B-NHL)

Aktive Filter

Suchergebnisse filtern